Reference number : 236-2017-2018-Q1-00464, amendment number : , agreement type : G, recipient legal name : Zarychanski, Ryan, recipient country : CA, recipient province : MB, recipient city : Winnipeg, recipient postal code : R3T 2N2, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 631125.0, agreement start date : 2017-04-01, agreement end date : 2020-03-31, description english : Heparin anticoagulation to improve outcomes in septic shock: The HALO International Phase II Trial, description french : Heparin anticoagulation to improve outcomes in septic shock: The HALO International Phase II Trial, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2019-20), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2019-20), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada